Predictive validity of two process-of-care quality measures for residential substance use disorder treatment

Addiction Science and Clinical Practice

Volumn 10, Issue 1, 2015, Pages

  Harris, Alex H S ^a   Gupta, Shalini ^a   Bowe, Thomas ^a   Ellerbe, Laura S ^a   Phelps, Tyler E ^a   Rubinsky, Anna D ^a   Finney, John W ^a   Asch, Steven M ^a   Humphreys, Keith ^a   Trafton, Jodie ^a  

^a VA PALO ALTO HEALTH CARE SYSTEM   (United States)

Author keywords

Continuing care; Quality measurement; Residential treatment; Retension

Indexed keywords

ADULT; DRUG DEPENDENCE TREATMENT; FEMALE; GOVERNMENT; HEALTH CARE QUALITY; HOSPITAL DISCHARGE; HUMAN; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; PATIENT CARE; PROPENSITY SCORE; REPRODUCIBILITY; RESIDENTIAL CARE; SEVERITY OF ILLNESS INDEX; STANDARDS; TREATMENT OUTCOME; UNITED STATES;

ADULT; CONTINUITY OF PATIENT CARE; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT DISCHARGE; PROPENSITY SCORE; QUALITY INDICATORS, HEALTH CARE; QUALITY OF HEALTH CARE; REPRODUCIBILITY OF RESULTS; RESIDENTIAL TREATMENT; SEVERITY OF ILLNESS INDEX; SUBSTANCE ABUSE TREATMENT CENTERS; UNITED STATES; UNITED STATES DEPARTMENT OF VETERANS AFFAIRS;

EID: 85013035658     PISSN: 19400632     EISSN: 19400640     Source Type: Journal    
DOI: 10.1186/s13722-015-0042-5     Document Type: Article

References (26)

1. Bradley KA, et al. When quality indicators undermine quality: bias in a quality indicator of follow-up for alcohol misuse. Psychiatr Serv. 2013;64(10):1018-25.
2. Harris AH, et al. Measuring the quality of substance use disorder treatment: evaluating the validity of the Department of Veterans Affairs continuity of care performance measure. J Subst Abuse Treat. 2009;36(3):294-305.
3. Iezzoni LI. The risks of risk adjustment. JAMA. 1997;278(19):1600-7.
4. Harris AHS, et al. Validation of the treatment identification strategy of the HEDIS addiction quality measures: concordance with medical record review. BMC Health Serv Res. 2011;11:73.
5. Parast L, et al. Challenges in assessing the process-outcome link in practice. J Gen Intern Med. 2015;30(3):359-64.
6. Werner RM, Bradlow ET. Relationship between Medicare's hospital compare performance measures and mortality rates. JAMA. 2006;296(22):2694-702.
7. Horn SD. Performance measures and clinical outcomes. JAMA. 2006;296(22):2731-2.
8. Wachter RM, et al. Public reporting of antibiotic timing in patients with pneumonia: lessons from a flawed performance measure. Ann Intern Med. 2008;149(1):29-32.
9. Walter LC, et al. Pitfalls of converting practice guidelines into quality measures: lessons learned from a VA performance measure. JAMA. 2004;291(20):2466-70.
10. Roth S, et al. Unintended consequences of a quality measure for acute bronchitis. Am J Manag Care. 2012;18(6):e217-24.
11. Harris AH, et al. HEDIS initiation and engagement quality measures of substance use disorder care: impact of setting and health care specialty. Popul Health Manag. 2009;12(4):191-6.
12. Harris AH, et al. Does meeting the HEDIS substance abuse treatment engagement criterion predict patient outcomes? J Behav Health Serv Res. 2010;37(1):25-39.
13. Dunigan R, et al. Engagement in outpatient substance abuse treatment and employment outcomes. J Behav Health Serv Res. 2014;41(1):20-36.
14. Garnick DW, et al. The Washington Circle engagement performance measures' association with adolescent treatment outcomes. Drug Alcohol Depend. 2012;124(3):250-8.
15. Harris AH, Humphreys K, Finney JW. Veterans affairs facility performance on Washington Circle indicators and casemix-adjusted effectiveness. J Subst Abuse Treat. 2007;33(4):333-9.
16. Garnick DW, et al. Adapting Washington Circle performance measures for public sector substance abuse treatment systems. J Subst Abuse Treat. 2009;36(3):265-77.
17. Garner BR, et al. The Washington Circle Continuity of Care performance measure: predictive validity with adolescents discharged from residential treatment. J Subst Abuse Treat. 2010;38(1):3-11.
18. Peterson KA, et al. Determinants of readmission following inpatient substance abuse treatment: a national study of VA programs. Med Care. 1994;32(6):535-50.
19. Trafton JA, et al. VHA mental health information system: applying health information technology to monitor and facilitate implementation of VHA Uniform Mental Health Services Handbook requirements. Med Care. 2013;51(3 Suppl 1):S29-36.
20. McCaffrey DF, Ridgeway G, Morral AR. Propensity score estimation with boosted regression for evaluating causal effects in observational studies. Psychol Methods. 2004;9(4):403-25.
21. Desai M, Begg MD. A comparison of regression approaches for analyzing clustered data. Am J Public Health. 2008;98(8):1425-9.
22. Harris AHS, et al. Measuring the quality of substance use disorder treatment: evaluating the validity of the Department of Veterans Affairs continuity of care performance measure. J Subst Abuse Treat. 2009;36(3):294-305.
23. Greenberg G, Rosenheck R, Fontana A. Continuity of Care and clinical effectiveness: treatment of posttraumatic stress disorder in the Department of Veterans Affairs. J Behav Health Ser Res. 2003;30:202-14.
24. Greenberg A, Rosenheck R, Seibyl C. Continuity of care and clinical effectiveness: outcomes following residential treatment for severe substance abuse. Med Care. 2002;40(3):246-59.
25. Adair CE, et al. Continuity of care and health outcomes among persons with severe mental illness. Psychiatr Serv. 2005;56(9):1061-9.
26. Greenberg GA, Rosenheck RA. Continuity of care and clinical outcomes in a national health system. Psychiatr Serv. 2005;56(4):427-33.